[go: up one dir, main page]

DE60118198D1 - Fettsäure-analoge zur behandlung von krebs - Google Patents

Fettsäure-analoge zur behandlung von krebs

Info

Publication number
DE60118198D1
DE60118198D1 DE60118198T DE60118198T DE60118198D1 DE 60118198 D1 DE60118198 D1 DE 60118198D1 DE 60118198 T DE60118198 T DE 60118198T DE 60118198 T DE60118198 T DE 60118198T DE 60118198 D1 DE60118198 D1 DE 60118198D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
fatty acid
treatment
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60118198T
Other languages
English (en)
Other versions
DE60118198T2 (de
Inventor
Rolf Berge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thia Medica AS
Original Assignee
Thia Medica AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica AS filed Critical Thia Medica AS
Publication of DE60118198D1 publication Critical patent/DE60118198D1/de
Application granted granted Critical
Publication of DE60118198T2 publication Critical patent/DE60118198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60118198T 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs Expired - Fee Related DE60118198T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20003591 2000-07-13
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer

Publications (2)

Publication Number Publication Date
DE60118198D1 true DE60118198D1 (de) 2006-05-11
DE60118198T2 DE60118198T2 (de) 2007-01-25

Family

ID=19911376

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118198T Expired - Fee Related DE60118198T2 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs

Country Status (17)

Country Link
US (1) US7378443B2 (de)
EP (1) EP1313463B1 (de)
JP (1) JP2004502732A (de)
KR (2) KR20080071598A (de)
CN (1) CN100569228C (de)
AT (1) ATE320802T1 (de)
AU (2) AU2001272860B2 (de)
BR (1) BR0112399A (de)
CA (1) CA2414480A1 (de)
DE (1) DE60118198T2 (de)
ES (1) ES2261441T3 (de)
MX (1) MXPA02012944A (de)
NO (2) NO20003591L (de)
NZ (1) NZ523316A (de)
RU (1) RU2283105C2 (de)
WO (1) WO2002003983A1 (de)
ZA (1) ZA200210028B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
WO2004000854A1 (en) 2002-06-20 2003-12-31 Ic Vec Limited Sulfur-containing phospholipid derivatives
EP1784223A2 (de) 2004-07-19 2007-05-16 Thia Medica AS Zusammensetzung enthaltend pflanzen- oder fischöl und nicht-oxidierbaren fettsäuren
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
EP2724739B1 (de) 2009-07-30 2015-07-01 Tandem Diabetes Care, Inc. Tragbares Infusionspumpensystem
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US10154979B2 (en) 2013-03-11 2018-12-18 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
JP2018519278A (ja) * 2015-06-11 2018-07-19 ユニバーシティー オブ マイアミＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉａｍｉ 癌の治療及び診断
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
AU693682B2 (en) * 1995-04-10 1998-07-02 Taiho Pharmaceutical Co., Ltd. Cancerous metastasis inhibitor
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
AU5601898A (en) * 1996-12-11 1998-07-03 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumour cell growth
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Also Published As

Publication number Publication date
ZA200210028B (en) 2004-01-26
HK1057473A1 (zh) 2004-04-08
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
EP1313463A1 (de) 2003-05-28
KR20030016399A (ko) 2003-02-26
KR100861428B1 (ko) 2008-10-02
NO20025930L (no) 2003-01-13
AU7286001A (en) 2002-01-21
BR0112399A (pt) 2003-05-27
ES2261441T3 (es) 2006-11-16
NZ523316A (en) 2004-09-24
US20040024063A1 (en) 2004-02-05
KR20080071598A (ko) 2008-08-04
RU2283105C2 (ru) 2006-09-10
CN1441671A (zh) 2003-09-10
NO324634B1 (no) 2007-11-26
CN100569228C (zh) 2009-12-16
AU2001272860B2 (en) 2005-11-24
NO20003591L (no) 2002-01-14
US7378443B2 (en) 2008-05-27
CA2414480A1 (en) 2002-01-17
ATE320802T1 (de) 2006-04-15
EP1313463B1 (de) 2006-03-22
WO2002003983A1 (en) 2002-01-17
DE60118198T2 (de) 2007-01-25
MXPA02012944A (es) 2004-05-17
JP2004502732A (ja) 2004-01-29

Similar Documents

Publication Publication Date Title
DE60118198D1 (de) Fettsäure-analoge zur behandlung von krebs
BR9910296A (pt) Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
TW200600096A (en) Prodrugs of piperazine and substituted piperidine antiviral agents
DK1485359T3 (da) Natriumkanalblokkere
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
ES2193874B1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
ATE238981T1 (de) Antitumorwirkstoffe
DE60137243D1 (de) Fettsäure-analogen zur behandlung proliferierender hautstörungen
TW200640532A (en) Oral compositions containing biphenol antibacterial compounds
DE69839781D1 (en) Heterocyclische topoisomerase toxine
EP0781667A3 (de) Reversibele thermochromische Zusammensetzung
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
AU2003300385A8 (en) Anticancer compounds
BRPI0411664A (pt) composição oral antiplaca aquosa estável
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
EP0815111A4 (de) Analoge von n-acetylardeemin, verfahren zur herstellung und verwendung dieser analogen
DE60308171D1 (de) Haarpflegemittel, die phenolische haarformungsmittel enthalten
NO20023041D0 (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
TW200724131A (en) Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods
SE9800932D0 (sv) New compunds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee